Tumor Mutational Burden: A Continually Evolving Biomarker for Immunotherapy
MarketScreener,
Dan Brudzewsky, PhD Senior Field Applications Scientist - UK
Dan Brudzewsky, PhD Senior Field Applications Scientist - UK
— The (CRI) and The Mark Foundation for Cancer Research have launched an innovative clinical trial that aims to demonstrate the…
Post Views: 2 NEW YORK, July 29, 2020 The Cancer Research Institute (CRI) and The Mark Foundation for Cancer Research have…
Multiple ongoing clinical trials are now incorporating checkpoint inhibitors in the neoadjuvant setting for early-stage non-small…
Blood-based liquid biopsies can accurately track lung cancer treatment responses by measuring circulating tumor DNA (ctDNA…
The results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer…
Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer…
Credit: Cancer Research MEDIA CONTACT Available for logged-in reporters only TYPE OF ARTICLE Research Results All Journal News…
Results of two clinical studies have added to evidence that blood-based liquid biopsies can accurately track lung cancer…